These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25333508)

  • 1. Fasudil inhibits prostate cancer-induced angiogenesis in vitro.
    Chen W; Mao K; Hua-Huy T; Bei Y; Liu Z; Dinh-Xuan AT
    Oncol Rep; 2014 Dec; 32(6):2795-802. PubMed ID: 25333508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.
    Yin L; Morishige K; Takahashi T; Hashimoto K; Ogata S; Tsutsumi S; Takata K; Ohta T; Kawagoe J; Takahashi K; Kurachi H
    Mol Cancer Ther; 2007 May; 6(5):1517-25. PubMed ID: 17513600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
    Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
    Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasudil inhibits lung carcinoma-conditioned endothelial cell viability and migration.
    Zhang Z; Ren JH; Li ZY; Nong L; Wu G
    Oncol Rep; 2012 May; 27(5):1561-6. PubMed ID: 22344855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
    Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Chen J; Li ZY; Zhang RG; Zhu F; Wu G
    Mol Cancer Ther; 2015 Jul; 14(7):1582-90. PubMed ID: 25934709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion.
    Li H; Peng W; Jian W; Li Y; Li Q; Li W; Xu Y
    Cardiovasc Diabetol; 2012 Jun; 11():65. PubMed ID: 22694757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
    Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
    Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L; Li G; Li R; Liu Q; He Q; Zhang J
    Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
    Gao H; Hou F; Dong R; Wang Z; Zhao C; Tang W; Wu Y
    Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraradial administration of fasudil inhibits augmented Rho kinase activity to effectively dilate the spastic radial artery during coronary artery bypass grafting surgery.
    Takagi T; Okamoto Y; Tomita S; Sato A; Yamaguchi S; Takuwa Y; Watanabe G
    J Thorac Cardiovasc Surg; 2011 Aug; 142(2):e59-65. PubMed ID: 21397262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
    Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
    Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.
    Hata Y; Miura M; Nakao S; Kawahara S; Kita T; Ishibashi T
    Jpn J Ophthalmol; 2008; 52(1):16-23. PubMed ID: 18369695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
    Yang X; Di J; Zhang Y; Zhang S; Lu J; Liu J; Shi W
    Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fasudil inhibits HSC adhesion, migration and proliferation via Rho/ROCK pathway].
    Wang YZ; Jiang HQ; Hu CX; Chen X
    Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):821-3. PubMed ID: 17125608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rho kinase inhibitor fasudil inhibits the migratory behaviour of 95-D lung carcinoma cells.
    Yang X; Liu Y; Zong Z; Tian D
    Biomed Pharmacother; 2010 Jan; 64(1):58-62. PubMed ID: 19879105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.
    Nakabayashi H; Shimizu K
    Cancer Sci; 2011 Feb; 102(2):393-9. PubMed ID: 21166955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
    Zhu F; Zhang Z; Wu G; Li Z; Zhang R; Ren J; Nong L
    Med Oncol; 2011 Jun; 28(2):565-71. PubMed ID: 20300976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fasudil on growth, adhesion, invasion, and migration of 95D lung carcinoma cells in vitro.
    Yang X; Zhang Y; Wang S; Shi W
    Can J Physiol Pharmacol; 2010 Sep; 88(9):874-9. PubMed ID: 20921973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.